From May to July, China's export growth rate of APIs fell
From January to July 2020, China's export volume of APIs reached USD 21.388 billion, a year-on-year increase of 6.2%. Judging from the monthly data, the export growth rate in a single month showed a trend of falling first, then rising, rising and falling. In February, due to the severe domestic epidemic, the late resumption of work and production, and the delayed delivery, the export value decreased by 28.81% year-on-year; entering March, the domestic epidemic was effectively controlled, and the overseas epidemic entered the outbreak period, and China’s previous delayed delivery of raw materials Drugs were shipped successively, and the export of APIs quickly recovered and achieved rapid growth, a year-on-year increase of 13.05%; India entered a state of lockdown in April, and its API production and exports were affected. The international market’s demand for China’s APIs Turnover orders rose sharply, and the export value of APIs in the month increased by 24.85% year-on-year; after that, as the global epidemic continued to spread, the explosive demand growth of APIs was short-lived, and China's export growth of APIs began to slow down, and exports from May to July The growth rate dropped gradually, reaching 15.55%, 5.52% and 0.89% respectively. However, with the second wave of overseas epidemics at the end of the year, China's export growth of APIs may show a small "tail-up".
Looking for chemical products? Let suppliers reach out to you!
2026-07-07
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
Recommend Reading
-
Sun Pharma’s Winning Formula: Precision Over Expansion
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
Pharma Companies to See 11 Percent Growth in Sales and EBITDA in Q1FY26
-
Sipcam Nichino Brasil Unveils Soleado Fungicide at Hortitec 2025
-
Alchem Fined $576,000 for Role in EU Pharmaceutical Cartel
-
Vendor Shipment Surge Halts Mid-October PC Price Increase
-
Ammonium Sulfate Market Prices First Decline Then Rise (August 1-7)
-
Change Rate Remains Positive, This Round of Refined Oil Retail Prices in China Is About to Increase
-
Stahl Reopens Ranipet Plant
-
Mitsubishi to Boost Thai Union Stake to 20 Percent with $200 Million Investment Global Seafood Supply Chain Strategy Accelerates